COVID-19 Impact on Global Alzheimer’s Disease Diagnostic Market Size, Status and Forecast 2020-2026

Published On: May 2020

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 161389

This report focuses on the global Alzheimer’s Disease Diagnostic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alzheimer’s Disease Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Eli Lilly and Company
Novartis
Merck
F. Hoffmann-La Roche
Pfizer
TauRx
Alector
Accera
Treventis Corporation
Neuro-Bio
Cognition Therapeutics

Market segment by Type, the product can be split into
Nervous System Examination
Genetic Testing
Minor Mental State Examination (Mmse)
Brain Imaging
Market segment by Application, split into
Early-Onset Alzheimer's Disease
Familial Alzheimer's Disease
Late-Onset Alzheimer's Disease

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Alzheimer’s Disease Diagnostic status, future forecast, growth opportunity, key market and key players.
To present the Alzheimer’s Disease Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Alzheimer’s Disease Diagnostic are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Alzheimer’s Disease Diagnostic Revenue
1.4 Market Analysis by Type
1.4.1 Global Alzheimer’s Disease Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Nervous System Examination
1.4.3 Genetic Testing
1.4.4 Minor Mental State Examination (Mmse)
1.4.5 Brain Imaging
1.5 Market by Application
1.5.1 Global Alzheimer’s Disease Diagnostic Market Share by Application: 2020 VS 2026
1.5.2 Early-Onset Alzheimer's Disease
1.5.3 Familial Alzheimer's Disease
1.5.4 Late-Onset Alzheimer's Disease
1.6 Coronavirus Disease 2019 (Covid-19): Alzheimer’s Disease Diagnostic Industry Impact
1.6.1 How the Covid-19 is Affecting the Alzheimer’s Disease Diagnostic Industry
1.6.1.1 Alzheimer’s Disease Diagnostic Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Alzheimer’s Disease Diagnostic Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Alzheimer’s Disease Diagnostic Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends by Regions
2.1 Alzheimer’s Disease Diagnostic Market Perspective (2015-2026)
2.2 Alzheimer’s Disease Diagnostic Growth Trends by Regions
2.2.1 Alzheimer’s Disease Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Alzheimer’s Disease Diagnostic Historic Market Share by Regions (2015-2020)
2.2.3 Alzheimer’s Disease Diagnostic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Alzheimer’s Disease Diagnostic Market Growth Strategy
2.3.6 Primary Interviews with Key Alzheimer’s Disease Diagnostic Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Alzheimer’s Disease Diagnostic Players by Market Size
3.1.1 Global Top Alzheimer’s Disease Diagnostic Players by Revenue (2015-2020)
3.1.2 Global Alzheimer’s Disease Diagnostic Revenue Market Share by Players (2015-2020)
3.1.3 Global Alzheimer’s Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Alzheimer’s Disease Diagnostic Market Concentration Ratio
3.2.1 Global Alzheimer’s Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Alzheimer’s Disease Diagnostic Revenue in 2019
3.3 Alzheimer’s Disease Diagnostic Key Players Head office and Area Served
3.4 Key Players Alzheimer’s Disease Diagnostic Product Solution and Service
3.5 Date of Enter into Alzheimer’s Disease Diagnostic Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Alzheimer’s Disease Diagnostic Historic Market Size by Type (2015-2020)
4.2 Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Type (2021-2026)

5 Alzheimer’s Disease Diagnostic Breakdown Data by Application (2015-2026)
5.1 Global Alzheimer’s Disease Diagnostic Market Size by Application (2015-2020)
5.2 Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Alzheimer’s Disease Diagnostic Market Size (2015-2020)
6.2 Alzheimer’s Disease Diagnostic Key Players in North America (2019-2020)
6.3 North America Alzheimer’s Disease Diagnostic Market Size by Type (2015-2020)
6.4 North America Alzheimer’s Disease Diagnostic Market Size by Application (2015-2020)

7 Europe
7.1 Europe Alzheimer’s Disease Diagnostic Market Size (2015-2020)
7.2 Alzheimer’s Disease Diagnostic Key Players in Europe (2019-2020)
7.3 Europe Alzheimer’s Disease Diagnostic Market Size by Type (2015-2020)
7.4 Europe Alzheimer’s Disease Diagnostic Market Size by Application (2015-2020)

8 China
8.1 China Alzheimer’s Disease Diagnostic Market Size (2015-2020)
8.2 Alzheimer’s Disease Diagnostic Key Players in China (2019-2020)
8.3 China Alzheimer’s Disease Diagnostic Market Size by Type (2015-2020)
8.4 China Alzheimer’s Disease Diagnostic Market Size by Application (2015-2020)

9 Japan
9.1 Japan Alzheimer’s Disease Diagnostic Market Size (2015-2020)
9.2 Alzheimer’s Disease Diagnostic Key Players in Japan (2019-2020)
9.3 Japan Alzheimer’s Disease Diagnostic Market Size by Type (2015-2020)
9.4 Japan Alzheimer’s Disease Diagnostic Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Alzheimer’s Disease Diagnostic Market Size (2015-2020)
10.2 Alzheimer’s Disease Diagnostic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Alzheimer’s Disease Diagnostic Market Size by Type (2015-2020)
10.4 Southeast Asia Alzheimer’s Disease Diagnostic Market Size by Application (2015-2020)

11 India
11.1 India Alzheimer’s Disease Diagnostic Market Size (2015-2020)
11.2 Alzheimer’s Disease Diagnostic Key Players in India (2019-2020)
11.3 India Alzheimer’s Disease Diagnostic Market Size by Type (2015-2020)
11.4 India Alzheimer’s Disease Diagnostic Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Alzheimer’s Disease Diagnostic Market Size (2015-2020)
12.2 Alzheimer’s Disease Diagnostic Key Players in Central & South America (2019-2020)
12.3 Central & South America Alzheimer’s Disease Diagnostic Market Size by Type (2015-2020)
12.4 Central & South America Alzheimer’s Disease Diagnostic Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Eli Lilly and Company
13.1.1 Eli Lilly and Company Company Details
13.1.2 Eli Lilly and Company Business Overview and Its Total Revenue
13.1.3 Eli Lilly and Company Alzheimer’s Disease Diagnostic Introduction
13.1.4 Eli Lilly and Company Revenue in Alzheimer’s Disease Diagnostic Business (2015-2020))
13.1.5 Eli Lilly and Company Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview and Its Total Revenue
13.2.3 Novartis Alzheimer’s Disease Diagnostic Introduction
13.2.4 Novartis Revenue in Alzheimer’s Disease Diagnostic Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview and Its Total Revenue
13.3.3 Merck Alzheimer’s Disease Diagnostic Introduction
13.3.4 Merck Revenue in Alzheimer’s Disease Diagnostic Business (2015-2020)
13.3.5 Merck Recent Development
13.4 F. Hoffmann-La Roche
13.4.1 F. Hoffmann-La Roche Company Details
13.4.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
13.4.3 F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Introduction
13.4.4 F. Hoffmann-La Roche Revenue in Alzheimer’s Disease Diagnostic Business (2015-2020)
13.4.5 F. Hoffmann-La Roche Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview and Its Total Revenue
13.5.3 Pfizer Alzheimer’s Disease Diagnostic Introduction
13.5.4 Pfizer Revenue in Alzheimer’s Disease Diagnostic Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 TauRx
13.6.1 TauRx Company Details
13.6.2 TauRx Business Overview and Its Total Revenue
13.6.3 TauRx Alzheimer’s Disease Diagnostic Introduction
13.6.4 TauRx Revenue in Alzheimer’s Disease Diagnostic Business (2015-2020)
13.6.5 TauRx Recent Development
13.7 Alector
13.7.1 Alector Company Details
13.7.2 Alector Business Overview and Its Total Revenue
13.7.3 Alector Alzheimer’s Disease Diagnostic Introduction
13.7.4 Alector Revenue in Alzheimer’s Disease Diagnostic Business (2015-2020)
13.7.5 Alector Recent Development
13.8 Accera
13.8.1 Accera Company Details
13.8.2 Accera Business Overview and Its Total Revenue
13.8.3 Accera Alzheimer’s Disease Diagnostic Introduction
13.8.4 Accera Revenue in Alzheimer’s Disease Diagnostic Business (2015-2020)
13.8.5 Accera Recent Development
13.9 Treventis Corporation
13.9.1 Treventis Corporation Company Details
13.9.2 Treventis Corporation Business Overview and Its Total Revenue
13.9.3 Treventis Corporation Alzheimer’s Disease Diagnostic Introduction
13.9.4 Treventis Corporation Revenue in Alzheimer’s Disease Diagnostic Business (2015-2020)
13.9.5 Treventis Corporation Recent Development
13.10 Neuro-Bio
13.10.1 Neuro-Bio Company Details
13.10.2 Neuro-Bio Business Overview and Its Total Revenue
13.10.3 Neuro-Bio Alzheimer’s Disease Diagnostic Introduction
13.10.4 Neuro-Bio Revenue in Alzheimer’s Disease Diagnostic Business (2015-2020)
13.10.5 Neuro-Bio Recent Development
13.11 Cognition Therapeutics
10.11.1 Cognition Therapeutics Company Details
10.11.2 Cognition Therapeutics Business Overview and Its Total Revenue
10.11.3 Cognition Therapeutics Alzheimer’s Disease Diagnostic Introduction
10.11.4 Cognition Therapeutics Revenue in Alzheimer’s Disease Diagnostic Business (2015-2020)
10.11.5 Cognition Therapeutics Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details